Monitoring the levels of serological laboratory markers, such as AFP, and inflammatory markers, such as C-reactive protein, has demonstrated a strong correlation with patient prognosis in cases of advanced HCC in some published studies [19,20]. This evidence concerns the gene AFP and hepatocellular carcinoma.